These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2277321)

  • 1. Technical report: bioburden recovery validation. PDA Bioburden Recovery Validation Task Force. Parenteral Drug Association.
    J Parenter Sci Technol; 1990; 44(6):324-31. PubMed ID: 2277321
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid/automated ID methods survey. PDA Microbial ID Task Force. Parenteral Drug Association.
    J Parenter Sci Technol; 1990; 44(4):216-22. PubMed ID: 2213430
    [No Abstract]   [Full Text] [Related]  

  • 3. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association.
    J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417
    [No Abstract]   [Full Text] [Related]  

  • 4. Validation of Milliflex
    Gordon O; Goverde M; Staerk A; Roesti D
    PDA J Pharm Sci Technol; 2017; 71(3):206-224. PubMed ID: 28196917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Report on survey of current industry gowning practices. PDA Gowning Task Force. Parenteral Drug Association.
    J Parenter Sci Technol; 1990; 44(4):223-7. PubMed ID: 2213431
    [No Abstract]   [Full Text] [Related]  

  • 6. PDA Technical Report No. 30: parametric release of pharmaceuticals terminally sterilized by moist heat. PDA Parametric Release Task Force.
    PDA J Pharm Sci Technol; 1999; 53(4):217-22. PubMed ID: 10754715
    [No Abstract]   [Full Text] [Related]  

  • 7. Validation and environmental monitoring of aseptic processing. Committee on Microbial Purity.
    J Parenter Sci Technol; 1990; 44(5):272-7. PubMed ID: 2250203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of the forthcoming PDA task force report on the inspection for visible particles in parenteral products: practical answers for present problems.
    Knapp JZ
    PDA J Pharm Sci Technol; 2003; 57(2):131-9. PubMed ID: 14674515
    [No Abstract]   [Full Text] [Related]  

  • 9. Validation of moist heat sterilization processes: cycle design, development, qualification and ongoing control.
    Parenteral Drug Association
    PDA J Pharm Sci Technol; 2007; 61(1 Suppl TR1):2-51. PubMed ID: 17966927
    [No Abstract]   [Full Text] [Related]  

  • 10. Sterility assurance from post-filling heat treatment.
    Enzinger RM
    J Parenter Sci Technol; 1990; 44(6):294-5. PubMed ID: 2277314
    [No Abstract]   [Full Text] [Related]  

  • 11. Validation and control of non-standard sterilization processes. Committee on Microbial Purity. FIP (International Pharmaceutical Federation).
    J Parenter Sci Technol; 1993; 47(1):9-15. PubMed ID: 8445502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steam sterilization of L.Y.P.'s: an integrated approach to sterilization assurance.
    Mascoli CC
    J Pharm Belg; 1977; 32(5):516-9. PubMed ID: 609038
    [No Abstract]   [Full Text] [Related]  

  • 13. [Radiation sterilization of monocarboxycellulose-based preparations].
    Iasnitskiĭ BG; Oridoroga VA; Pavlov EP; Tushov ZG; Oridoroga LM
    Farmatsiia; 1980; 29(3):15-7. PubMed ID: 7409212
    [No Abstract]   [Full Text] [Related]  

  • 14. Application of membrane filtration for removal of diminutive bioburden organisms in pharmaceutical products and processes.
    Sundaram S; Auriemma M; Howard G; Brandwein H; Leo F
    PDA J Pharm Sci Technol; 1999; 53(4):186-201. PubMed ID: 10754712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sterilizing filtration of liquids. Technical report no. 26. Parenteral Drug Association.
    PDA J Pharm Sci Technol; 1998; 52 Suppl 1():1-31. PubMed ID: 9693385
    [No Abstract]   [Full Text] [Related]  

  • 16. Design control and validation of a facility for sterile clinical trial preparations.
    Staines L
    J Parenter Sci Technol; 1984; 38(3):109-14. PubMed ID: 6747778
    [No Abstract]   [Full Text] [Related]  

  • 17. Industrial perspective on validation of tangential flow filtration in biopharmaceutical applications. Technical Report No. 15. Parenteral Drug Association. Biotechnology Task Force on Purification and Scale-up.
    J Parenter Sci Technol; 1992; 46 Suppl 1():S1-13. PubMed ID: 1432457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of compounding on sterility and stability of drugs.
    Hardee GE
    J Am Vet Med Assoc; 1994 Jul; 205(2):224-5. PubMed ID: 7928582
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceutical GMPs.
    Bobrowicz G
    Qual Assur; 1994 Jun; 3(2):138-48. PubMed ID: 7804629
    [No Abstract]   [Full Text] [Related]  

  • 20. Fundamentals of a microbiological environmental monitoring program. Technical Report No. 13. PDA Environmental Task Force.
    J Parenter Sci Technol; 1990; 44 Suppl 1():S1-16. PubMed ID: 2213434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.